Predictive value of circulating tumor tissue-modified HPV DNA kinetics in induction therapy for oropharyngeal squamous cell carcinoma
- 20 August 2025
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 169, 107608
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2025
- Pretreatment Liquid Biopsy and Clinicopathologic Features in HPV−Associated Oropharyngeal Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2025
- Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus–Associated Oropharyngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2023
- Association of Pretreatment Circulating Tumor Tissue–Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2022
- Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV‐positive head and neck cancerInternational Journal of Cancer, 2022
- Cell‐free human papillomavirus DNA kinetics after surgery for human papillomavirus–associated oropharyngeal cancerCancer, 2022
- Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experienceOral Oncology, 2021
- Treatment tolerability and outcomes in elderly patients with head and neck cancerHead & Neck, 2020
- Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trialOral Oncology, 2019
- Data Analysis2016